Select Your Region

We noticed you visit this page from United States. Please select your preferred region to continue

skip to content

Country Selector

Based on your location

Europe

North America

Latin America

Asia-Pacific

Healthcare Professional Verification

This section contains medical information for licensed healthcare professionals only. Please confirm your professional status to continue.

Road-traffic accidents: CDT, a reliable marker for chronic alcohol abuse testing

This webinar aims to outline the importance and diagnostic specificity of CDT (Carbohydrate-Deficient Transferrin) as a marker of chronic alcohol abuse, particularly in the context of forensic settings.

The strong analytical performance of CDT will notably be exposed, with a specific focus on its association with the risk of road traffic accidents under alcohol abuse.

This webinar is presented in English.

Publié: 5/15/2023 | Modifié: 8/7/2026

What will you learn?

  • Understand the diagnostic value of CDT

    Learn why Carbohydrate-Deficient Transferrin (CDT) is considered a highly specific biomarker for identifying chronic alcohol abuse.

  • Explore the analytical performance of CDT testing

    Discover the strengths and reliability of CDT measurement and its role in supporting accurate laboratory assessment of long-term alcohol consumption.

  • Assess the link between alcohol abuse and road traffic accidents

    Examine how CDT testing can be used in forensic settings to evaluate alcohol-related driving risks and support decision-making processes.

Only alcohol biomarker to have achieved full and international standardisation
Dr Nadia Maria Porpiglia Postdoctoral researcher Forensic Medicine Unit University of Verona, Italy

About Dr Nadia Maria Porpiglia

Bachelor’s degree in Biological Sciences, Master’s degree, and PhD in Forensic Science.

Following various study and work experiences abroad in the field of forensic sciences, Dr. Porpiglia has been working for six years as a research fellow at the Forensic Toxicology laboratories of the Institute of Forensic Medicine in Verona, where she has expanded her knowledge and use of analytical techniques in this field, including capillary electrophoresis, HPLC and mass spectrometry. In particular, in recent years Dr. Porpiglia has gained experience in chronic alcohol abuse with a focus on CDT.

Dr. Porpiglia has published book chapters and scientific articles related to forensic toxicology and contributed to national and international conferences. Among others, she is the first author of papers emphasizing the analytical and clinical interest of CDT for chronic alcohol abuse and its importance in the context of road traffic accident risk predictivity.

Dr. Porpiglia is a member of the Italian Group of Forensic Toxicologists (GTFI) and collaborates with the Working Group for CDT (WG-CDT) established by the IFCC (International Federation of Clinical Chemistry and Laboratory Medicine).

Dr Nadia Maria Porpiglia

Test associated with this resource

Deepen your expertise with additional webinars

This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country. Please contact your local Sebia representative. Information intended for healthcare professionals. Carefully read the instructions in the reagent package inserts and instrument manuals.

Road-traffic accidents: CDT, a reliable marker for chronic alcohol abuse testing